These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 29348981

  • 1. Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction.
    Jonasson M, Appel L, Danfors T, Nyholm D, Askmark H, Frick A, Engman J, Furmark T, Sörensen J, Lubberink M.
    Am J Nucl Med Mol Imaging; 2017; 7(6):263-274. PubMed ID: 29348981
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [11C]PE2I PET-MR brain imaging.
    Sousa JM, Appel L, Merida I, Heckemann RA, Costes N, Engström M, Papadimitriou S, Nyholm D, Ahlström H, Hammers A, Lubberink M.
    EJNMMI Phys; 2020 Dec 28; 7(1):77. PubMed ID: 33369700
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with ¹⁸F-FE-PE2I.
    Ikoma Y, Sasaki T, Kimura Y, Seki C, Okubo Y, Suhara T, Ito H.
    Ann Nucl Med; 2015 Oct 28; 29(8):697-708. PubMed ID: 26134215
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
    Sonni I, Fazio P, Schain M, Halldin C, Svenningsson P, Farde L, Varrone A.
    J Nucl Med; 2016 Oct 28; 57(10):1529-1534. PubMed ID: 27230923
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
    Seki C, Ito H, Ichimiya T, Arakawa R, Ikoma Y, Shidahara M, Maeda J, Takano A, Takahashi H, Kimura Y, Suzuki K, Kanno I, Suhara T.
    Ann Nucl Med; 2010 May 28; 24(4):249-60. PubMed ID: 20364374
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET.
    Jakobson Mo S, Axelsson J, Stiernman L, Riklund K.
    EJNMMI Res; 2022 Nov 17; 12(1):72. PubMed ID: 36394638
    [Abstract] [Full Text] [Related]

  • 15. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
    Sasaki T, Ito H, Kimura Y, Arakawa R, Takano H, Seki C, Kodaka F, Fujie S, Takahata K, Nogami T, Suzuki M, Fujiwara H, Takahashi H, Nakao R, Fukumura T, Varrone A, Halldin C, Nishikawa T, Suhara T.
    J Nucl Med; 2012 Jul 17; 53(7):1065-73. PubMed ID: 22689927
    [Abstract] [Full Text] [Related]

  • 16. Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease.
    Ivanidze J, Skafida M, Pandya S, Patel D, Osborne JR, Raj A, Gupta A, Henchcliffe C, Dyke JP.
    Front Neurosci; 2020 Jul 17; 14():528809. PubMed ID: 33071729
    [Abstract] [Full Text] [Related]

  • 17. PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.
    Bang JI, Jung IS, Song YS, Park HS, Moon BS, Lee BC, Kim SE.
    Nucl Med Biol; 2016 Feb 17; 43(2):158-64. PubMed ID: 26872440
    [Abstract] [Full Text] [Related]

  • 18. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A.
    J Nucl Med; 2015 May 17; 56(5):714-20. PubMed ID: 25791993
    [Abstract] [Full Text] [Related]

  • 19. Deep learning based low-activity PET reconstruction of [11C]PiB and [18F]FE-PE2I in neurodegenerative disorders.
    Daveau RS, Law I, Henriksen OM, Hasselbalch SG, Andersen UB, Anderberg L, Højgaard L, Andersen FL, Ladefoged CN.
    Neuroimage; 2022 Oct 01; 259():119412. PubMed ID: 35753592
    [Abstract] [Full Text] [Related]

  • 20. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
    Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, Lee MS.
    PLoS One; 2015 Oct 01; 10(7):e0132585. PubMed ID: 26147749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.